• Latest
Drugmakers yet to see gains from government’s minimum import price policy

Drugmakers yet to see gains from government’s minimum import price policy

June 23, 2026

Ethiopia, Eritrea break ties: Does the conflict risk becoming regional war? | Conflict News

October 2, 2026

What legal options does Centre have to intervene?

October 2, 2026

Escalator maintenance company slapped with S$15K fine after elderly man & woman fell in Hougang

October 2, 2026

Üstel says Greek Cypriot military build-up undermines peace rhetoric

October 2, 2026

Rep. Brian Poe seeks P100-M funding for ube industry

October 2, 2026

PM Modi Speaks To Flydubai Pilot Smit Machchhar After Alleged Mid-Air Attack, Says ‘Country Is Praying For You’

October 2, 2026

Doha & Abu Dhabi Airports Named World’s Most Beautiful

October 2, 2026

National programme launched to ensure “Poison-Free Fruits for Children” – Sri Lanka Mirror – Right to Know. Power to Change

October 2, 2026

Over 10 Afghan nationals detained in Karachi

October 2, 2026

Serdar Berdimuhamedov’s gas strategy extends from exports to methane efficiency

October 2, 2026

Sujeet Kalkal beats Afghanistan’s Sayed Omar Zazai to enter 65kg wrestling quarterfinals

October 2, 2026

Hundreds join Viksit Bharat Run at Indian Embassy in Muscat

October 2, 2026
Friday, October 2, 2026
  • About us
  • Advertise with us
  • Submit Articles
  • Privacy Policy
  • Contact us
Asia Today
No Result
View All Result
Subscribe
  • Login
  • Eastern Asia
    • China
    • Japan
    • Mongolia
    • North Korea
    • South Korea
  • South-eastern Asia
    • Brunei
    • Cambodia
    • Indonesia
    • Laos
    • Malaysia
    • Myanmar
    • Philippines
    • Singapore
    • Thailand
    • Timor Leste
    • Vietnam
  • Southern Asia
    • Afghanistan
    • Bangladesh
    • Bhutan
    • India
    • Iran
    • Maldives
    • Nepal
    • Pakistan
    • Sri Lanka
  • Central Asia
    • Kazakhstan
    • Kyrgyzstan
    • Tajikistan
    • Turkmenistan
    • Uzbekistan
  • Western Asia
    • Armenia
    • Azerbaijan
    • Bahrain
    • Cyprus
    • Georgia
    • Iraq
    • Israel
    • Jordan
    • Kuwait
    • Lebanon
    • Oman
    • Qatar
    • Saudi Arabia
    • State of Palestine
    • Syria
    • Turkey
    • United Arab Emirates
    • Yemen
  • More News
    • Opinion
    • Politics
    • Business
    • Entertainment
    • Fashion
    • Food
    • Health
    • Lifestyle
    • Science
    • Tech
    • Sports
  • Eastern Asia
    • China
    • Japan
    • Mongolia
    • North Korea
    • South Korea
  • South-eastern Asia
    • Brunei
    • Cambodia
    • Indonesia
    • Laos
    • Malaysia
    • Myanmar
    • Philippines
    • Singapore
    • Thailand
    • Timor Leste
    • Vietnam
  • Southern Asia
    • Afghanistan
    • Bangladesh
    • Bhutan
    • India
    • Iran
    • Maldives
    • Nepal
    • Pakistan
    • Sri Lanka
  • Central Asia
    • Kazakhstan
    • Kyrgyzstan
    • Tajikistan
    • Turkmenistan
    • Uzbekistan
  • Western Asia
    • Armenia
    • Azerbaijan
    • Bahrain
    • Cyprus
    • Georgia
    • Iraq
    • Israel
    • Jordan
    • Kuwait
    • Lebanon
    • Oman
    • Qatar
    • Saudi Arabia
    • State of Palestine
    • Syria
    • Turkey
    • United Arab Emirates
    • Yemen
  • More News
    • Opinion
    • Politics
    • Business
    • Entertainment
    • Fashion
    • Food
    • Health
    • Lifestyle
    • Science
    • Tech
    • Sports
No Result
View All Result
Morning News
No Result
View All Result
Home Health

Drugmakers yet to see gains from government’s minimum import price policy

by Asia Today Team
June 23, 2026
in Health
Reading Time: 2 mins read
21 1
A A
0
Drugmakers yet to see gains from government’s minimum import price policy
25
SHARES
309
VIEWS
Share on FacebookShare on Twitter

READ ALSO

Fortis says it was ‘complete stranger’ to Daiichi-Singh Brothers arbitration dispute

Frightening Scenes In Rajkot As Injured India U-19 Pacer Stretchered Off


New Delhi: The federal government’s efforts to assist indigenous drug makers by means of the Minimal Import Worth (MIP) framework is but to see a transparent useful impression, a number of trade executives advised ET. Earlier this 12 months the federal government had restricted home pharmaceutical corporations from importing a couple of key uncooked supplies beneath a threshold pricing.

The MIP was set for some key pharmaceutical inputs like penicillin G and its salts, 6 APA and amoxicillin. In line with the notification from the Directorate Basic of Overseas Commerce (DGFT), the import worth for penicillin, a key uncooked materials for antibiotics, was set at ₹2,216 per kg, for amoxicillin the import worth was fastened at ₹2,733 per kg and ₹3,405 per kg for 6-APA.

Additionally Learn: Stress, poor sleep and processed meals are driving coronary heart assaults in younger Indians: Ramakanta Panda

“Demand is but to return and that raises considerations concerning the effectiveness of a coverage to bolster home pharmaceutical manufacturing,” one senior government advised ET. He added that the federal government’s clear intent to strengthen the Make in India agenda by means of the MIP mechanism has not discovered the anticipated traction from consumers, merchants, and completed dosage kind (FDF) producers who’ve been gradual or reluctant to pivot towards home suppliers at MIP linked costs.

“Because of this, a major put in capability is mendacity underutilised,” he added.

ET logo

Reside Occasions


Additionally Learn: India bans 16 fixed-dose drug mixtures over security considerations

Nonetheless, others say that it is a passing section. “Many consumers had stocked up closely on a couple of uncooked supplies in anticipation of MIP kicking in, and that could possibly be one of many causes for the lukewarm response,” he famous.He added he’s hopeful that the stockpiles at the moment are regularly being consumed and as soon as they run out, consumers will supply contemporary materials.

“We acquired the MIP in September 2025, pre-war, and until date we’ve low volumes regardless of having double the capability India wants. MIP on ATS-8 fully debunks the parable of demand and provide,” mentioned Namit Joshi, chairman, Pharmexcil.



Source link

Tags: drugmakersGainsGOVERNMENTSimportMinimumpolicyprice

Related Posts

Health

Fortis says it was ‘complete stranger’ to Daiichi-Singh Brothers arbitration dispute

September 28, 2026
Health

Frightening Scenes In Rajkot As Injured India U-19 Pacer Stretchered Off

October 2, 2026
Health

Bollywood Mr. And Miss India Season 7 Set To Bring Together Emerging Talent With Yash Ahlawat Of Studio 19 Film

September 27, 2026
Health

Anthropic and OpenEvidence Collaborate to Expand AI-Powered Medical Support Globally, ETHealthworld

September 24, 2026
Health

Ozempic maker Novo Nordisk sets sights on hair-loss market

September 23, 2026
Health

President Trump signs Sanctioning Russia and Iran Act

September 22, 2026
Asia Today

Copyright © 2022 Asia Today.

Navigate Site

  • Disclaimer
  • Privacy Policy
  • Cookie Privacy Policy
  • DMCA
  • Terms and Conditions
  • Contact us

Follow Us

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
  • World
  • Eastern Asia
    • China
    • Japan
    • Mongolia
    • North Korea
    • South Korea
  • South-eastern Asia
    • Brunei
    • Cambodia
    • Indonesia
    • Laos
    • Malaysia
    • Myanmar
    • Philippines
    • Singapore
    • Thailand
    • Timor Leste
    • Vietnam
  • Southern Asia
    • Afghanistan
    • Sri Lanka
    • Bangladesh
    • Bhutan
    • India
    • Iran
    • Maldives
    • Nepal
    • Pakistan
    • Central Asia
    • Kazakhstan
    • Kyrgyzstan
    • Tajikistan
    • Turkmenistan
    • Uzbekistan
  • Western Asia
    • Armenia
    • Azerbaijan
    • Bahrain
    • Cyprus
    • Georgia
    • Iraq
    • Israel
    • Jordan
    • Kuwait
    • Lebanon
    • Oman
    • Qatar
    • Saudi Arabia
    • State of Palestine
    • Syria
    • Turkey
    • United Arab Emirates
    • Yemen
  • Opinion
  • Politics
  • Business
  • Entertainment
  • Fashion
  • Food
  • Health
  • Lifestyle
  • Science
  • Tech
  • Travel
  • Sports
  • About us
  • Advertise with us
  • Privacy Policy
  • Contact us
  • Support AsiaToday

Copyright © 2022 Asia Today.